For more information please contact +1 (888) 605-6579


Bronchitis is characterized as an inflammation of the mucous membranes of the bronchi, the airways that carry airflow from the trachea into the lungs. Bronchitis can be divided into two categories, acute and chronic, each of which has unique etiologies, pathologies, and therapies.

Acute bronchitis is characterized by the development of a cough, with or without the production of mucous that is coughed up from the respiratory tract. Acute bronchitis often occurs during the course of an acute viral illness such as the common cold or flu.

Chronic bronchitis is characterized by the presence of a productive cough that lasts for three months or more per year for at least two years. Chronic bronchitis most often develops due to recurrent injury to the airways caused by inhaled irritants. Smoking is the most common cause, followed by air pollution and occupational exposure to irritants.

Bronchitis and Live Cell Therapy

Cell therapies have been well tested for the treatment of respiratory diseases. In most cases,  thymus extract has been prescribed either as mono therapy or in combination with antibiotics. One physician concluded that thymus extract was “the treatment of choice”. He explained this bold statement by saying that “it effectively changed the natural course of the disease by working at the causative level.”

Double blind studies performed on children with reoccurring respiratory infections showed a boost in their immune system and a decrease in the number of yearly infections, as well as a reduction in the severity of the infections they  did suffer. Thymus has also been used successfully as a preventative therapy.

In adults, an improvement in their immune status (increase in their T-lymphocyte cells) could be found in about 70% of patients treated with thymus extract. This resulted in a reduction of their symptoms and eliminated the need for antibiotics.